Differential expression of novel tyrosine kinase substrates during breast cancer development

Differential expression of novel tyrosine kinase substrates during breast cancer development

10.1074/mcp.M700395-MCP200

Saved in:

Bibliographic Details
Main Authors:	Chen, Y., Choong, L.-Y., Tan, Y.-L., Shah, N., Chong, P.-K., Lim, Y.-P., Lin, Q., Hew, C.-L., Philp, R., Wong, C.-H., Ang, B.-K., Loh, M.-C.-S., Druker, B.J.
Other Authors:	BIOLOGICAL SCIENCES
Format:	Article
Published:	2012
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/30182
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Butein, a specific protein tyrosine kinase inhibitor
by: Yang, E.-B., et al.
Published: (2013)

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma
by: Chuah, B.Y.S., et al.
Published: (2014)

Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase
by: Meyer, T., et al.
Published: (2016)

Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives
by: Yang, E.B., et al.
Published: (2014)

Tyrosine kinase c-Abl regulates the survival of plasma cells
by: Li, Y.-F, et al.
Published: (2020)

Ptb domain-directed substrate targeting in a tyrosine kinase from the unicellular choanoflagellate monosiga brevicollis
by: Prieto-Echagüe V., et al.
Published: (2019)

Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells
by: Chen, Y., et al.
Published: (2012)

Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm
by: Goh, Y.-M., et al.
Published: (2011)

Structure and physiology of the RET receptor tyrosine kinase
by: Ibáñez, C.F.
Published: (2016)

Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase
by: Yang, E.B., et al.
Published: (2014)

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis
by: Teo, Y.L., et al.
Published: (2014)

Tyrosine kinase inhibitors: A new approach for asthma
by: Wong, W.S.F., et al.
Published: (2012)

Amino acids differentially regulate insulin receptor tyrosine kinase and phosphatidyl inositol-3-OH-kinase activities in human monocytes exposed to high glucose concentration
by: Srinivasan, V., et al.
Published: (2014)

Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells
by: Tay, S.-P., et al.
Published: (2014)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation
by: Choong, L.-Y., et al.
Published: (2014)

SPESIFIKASI TYROSIN KINASE SPERMATOZOA SAPI
by: NURYO.SEKARNOTO, 060112855
Published: (2005)

Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendations
by: Teo Y.L, et al.
Published: (2016)

Low expression of DYRK2 (dual specificity tyrosine phosphorylation regulated kinase 2) correlates with poor prognosis in colorectal cancer
by: Yan H., et al.
Published: (2019)

Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma
by: Duan, W., et al.
Published: (2012)

Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma
by: Duan, W., et al.
Published: (2012)

Mechanisms of Yersinia YopO kinase substrate specificity
by: Lee W.L., et al.
Published: (2020)

Inhibitors of the tyrosine kinase signaling cascade for asthma
by: Wong, W.S.F.
Published: (2012)

THE CPSBCD TYROSINE KINASE SYSTEM IN S.PNEUMONIAE
by: REI NAKAMOTO
Published: (2024)

The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase
by: Pravit Akarasereenont, et al.
Published: (2018)

Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing
by: Chan, K.-W., et al.
Published: (2014)

The protein kinase CK2 catalytic domain from Plasmodium falciparum: Crystal structure, tyrosine kinase activity and inhibition
by: Ruiz-Carrillo, D, et al.
Published: (2020)

Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma
by: Davids, M., et al.
Published: (2011)

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
by: Ng, K.P., et al.
Published: (2014)

Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection
by: Lim, M.X, et al.
Published: (2020)

Internalization of Aeromonas hydrophila by fish epithelial cells can be inhibited with a tyrosine kinase inhibitor
by: Tan, E., et al.
Published: (2014)

Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility
by: Chang, C.-J., et al.
Published: (2014)

Effect of genistein, a tyrosine-specific protein kinase inhibitor, on cell rounding by pH upshifting
by: Sit, K.H., et al.
Published: (2012)

Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
by: Kalesh, K.A., et al.
Published: (2014)

Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells
by: Yang, E.-B., et al.
Published: (2014)

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: From bench to bedside
by: Zhou, J., et al.
Published: (2011)

A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis
by: Jennifer Smith, et al.
Published: (2018)

Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors
by: Zhang, J., et al.
Published: (2014)

Time-resolved multimodal analysis of src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases
by: Jadwin, J.A, et al.
Published: (2020)

Targeted disruption of the tyrosine phosphatase PTPα leads to constitutive downregulation of the kinases Src and Fyn
by: Ponniah S., et al.
Published: (2018)